USD
+$0.00
(+0.00%
)At Close (As of Oct 21, 2025)
$2.90B
Market Cap
-
P/E Ratio
-1.52
EPS
$196.26
52 Week High
$107.00
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $825M |
Total Revenue | $2.4B |
Cost Of Revenue | $1.6B |
Costof Goods And Services Sold | $1.6B |
Operating Income | $43M |
Selling General And Administrative | $639M |
Research And Development | $89M |
Operating Expenses | $782M |
Investment Income Net | - |
Net Interest Income | -$96M |
Interest Income | $11M |
Interest Expense | $107M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $2.4M |
Income Before Tax | -$66M |
Income Tax Expense | $52M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$118M |
Comprehensive Income Net Of Tax | - |
Ebit | $41M |
Ebitda | $43M |
Net Income | -$118M |
Field | Value (USD) |
---|---|
Total Assets | $4.2B |
Total Current Assets | $1.4B |
Cash And Cash Equivalents At Carrying Value | $309M |
Cash And Short Term Investments | $309M |
Inventory | $585M |
Current Net Receivables | $203M |
Total Non Current Assets | $2.8B |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $741M |
Intangible Assets Excluding Goodwill | $741M |
Goodwill | $1.4B |
Investments | - |
Long Term Investments | $3M |
Short Term Investments | $1.2M |
Other Current Assets | $346M |
Other Non Current Assets | - |
Total Liabilities | $2.2B |
Total Current Liabilities | $556M |
Current Accounts Payable | $148M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $67M |
Total Non Current Liabilities | $1.7B |
Capital Lease Obligations | $59M |
Long Term Debt | $1.5B |
Current Long Term Debt | $51M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $1.6B |
Other Current Liabilities | $300M |
Other Non Current Liabilities | $10M |
Total Shareholder Equity | $2B |
Treasury Stock | - |
Retained Earnings | $690M |
Common Stock | $2.5M |
Common Stock Shares Outstanding | $24M |
Field | Value (USD) |
---|---|
Operating Cashflow | $204M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $241M |
Capital Expenditures | $79M |
Change In Receivables | - |
Change In Inventory | $17M |
Profit Loss | - |
Cashflow From Investment | -$89M |
Cashflow From Financing | -$56M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$12M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$118M |
Field | Value (USD) |
---|---|
Gross Profit | $825M |
Total Revenue | $2.4B |
Cost Of Revenue | $1.6B |
Costof Goods And Services Sold | $1.6B |
Operating Income | $43M |
Selling General And Administrative | $639M |
Research And Development | $89M |
Operating Expenses | $782M |
Investment Income Net | - |
Net Interest Income | -$96M |
Interest Income | $11M |
Interest Expense | $107M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $2.4M |
Income Before Tax | -$66M |
Income Tax Expense | $52M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$118M |
Comprehensive Income Net Of Tax | - |
Ebit | $41M |
Ebitda | $43M |
Net Income | -$118M |
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
ICU Medical, Inc. is a prominent global leader in the development and manufacturing of innovative medical devices, with a focus on infusion therapy and critical care solutions. Based in San Clemente, California, the company is dedicated to enhancing patient safety and improving healthcare outcomes through cutting-edge technologies. Its comprehensive product portfolio encompasses a wide array of infusion systems and critical care devices, addressing the diverse needs of medical settings worldwide. With a strong emphasis on strategic acquisitions and ongoing investment in research and development, ICU Medical is well-positioned to maintain its market leadership and drive sustainable growth within the healthcare industry.